Hutch News

Hutch News

Stories tagged 'immunology'

Improving cancer vaccines with T-cell programming nanoparticles

Dr. Matthias Stephan receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology

July 31, 2018 | By Sabrina Richards / Fred Hutch News Service

Fred Hutch immunobioengineer Dr. Matthias Stephan has received an award to support the development of a combined T-cell programming, cancer-vaccine strategy to treat cancer.

View story >


The legacy of a pioneering transplant immunologist

‘So much to be learned’: Dr. John Hansen reflects on the lives he’s saved and the answers still to come

July 11, 2018 | by Susan Keown / Fred Hutch News Service

Among his many contributions to bone marrow transplantation, Hansen helped define the rules for matching donors and patients and was a founding father of volunteer donor registries.

View story >


First human antibody found to block Epstein-Barr virus

Early research could open new path for vaccine against EBV-related cancers, mononucleosis

April 17, 2018 | By Mary Engel / Fred Hutch News Service

The finding opens a new path to developing a vaccine against EBV, a virus best known for causing mono but which is associated with about 200,000 cancer cases a year.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 22, 2016

Dr. Candice Grzelak gets $180K to study breast cancer mets; Infectious Disease Sciences earns training grant; Drs. Jesse Bloom, Frederick "Erick" Matsen named HHMI-Simons Faculty Scholars

View story >


Gut microbiome may have interfered with experimental HIV vaccines

Inoculating infants instead of adults could bypass problem, researchers say

July 30, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

New findings suggest that the gut microbiome’s influence on the childhood immune system may be the reason a promising experimental HIV vaccine failed to protect people from infection with the virus in recent clinical trials.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.